Table 3.
Figures of merit of the MCR-ALS regression model for the validation set of CHZ, CRZ, HAL, IMP, and PTN.
| Parameters | HAL | IMP | CHZ | CRZ | PNT | 
|---|---|---|---|---|---|
| Accuracy (mean ± SD)a | 99.3 ± 1.45 | 99.8 ± 1.55 | 99.8 ± 1.13 | 100.1 ± 1.45 | 99.9 ± 0.65 | 
| Precision repeatability (RSD%)b | 1.09 | 1.32 | 0.89 | 0.67 | 0.78 | 
| Intermediate precision (RSD%)c | 1.46 | 1.56 | 1.13 | 1.44 | 0.65 | 
| RMSEP | 6.56 × 10−2 | 6.17 × 10−2 | 1.65 × 10−2 | 7.81 × 10−2 | 5.54 × 10−2 | 
| SEP | 6.34 × 10−2 | 5.96 × 10−2 | 1.59 × 10−2 | 7.54 × 10−2 | 5.35 × 10−2 | 
| Bias | 6.96 × 10−3 | −1.74 × 10−2 | −2.36 × 10−3 | 2.07 × 10−2 | 6.74 × 10−3 | 
| RE (%) | 1.33 | 1.35 | 0.75 | 1.42 | 0.67 | 
| Correlation coefficient (r2) | 0.9994 | 0.9995 | 0.9997 | 0.9996 | 0.9998 | 
aThe mean and standard deviation for 15 determinations. bThe intraday relative standard deviation (n = 3), an average of three different concentration repeated three times within the same day. cThe interday relative standard deviation (n = 3), an average of three different concentration repeated three times in three different days. Low concentrations: 1 μg/mL for HAL, IMP, and CRZ, 0.5 μg/mL for CHZ, and 5 μg/mL for PTN. Intermediate concentrations: 5 μg/mL for HAL, IMP, and CRZ, 2.5 μg/mL for CHZ, and 10 μg/mL for PTN. High concentration: 10 μg/mL for HAL, IMP, and CRZ, 5 μg/mL for CHZ, and 20 μg/mL for PTN.